Dr Salima Sarah Nurmohamed has been awarded the John Goldman Fellowship for Future Science by the leukaemia research charity Leuka. The fellowship carries a grant of £100,000, and will support Dr Nurmohamed’s project characterizing GATA2, a key transcriptional regulator, in blood development and leukaemia.
The late Dr John Goldman was a renowned haematologist and a pioneer in the treatment of leukaemia, and Leuka is continuing his legacy with the John Goldman Fellowships for Future Science awards.
Leuka’s Chief Executive Olive Boles said, ‘Leuka recognizes the importance of investing in the most talented and innovative scientists, who need support to take chances in order to make progress. Hopefully, these individuals will go on to discover the breakthroughs of tomorrow...’
Dr Nurmohamed commented: ‘I am most honoured to have been awarded a John Goldman Fellowship for Future Science. The John Goldman award will allow me to pursue a vision to bridge scientific fields through collaboration, developing diversity that is key in finding a cure for leukaemia...’